ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 12

$533K Total Retail Price of All Prescriptions

Rank: 4 out of 12

456 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 10,588 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 467 434 S3 1 2
LISINOPRIL 432 408 2 3
SIMVASTATIN 420 404 3 7
AMLODIPINE BESYLATE 407 379 4 5
OMEPRAZOLE 361 319 5 8
FUROSEMIDE 332 325 6 4
LEVOTHYROXINE SODIUM 330 324 7 1
GABAPENTIN 328 297 8 9
POTASSIUM CHLORIDE 309 300 9 6
CITALOPRAM HBR 263 239 10 12
METOPROLOL TARTRATE 223 190 11 11
HYDROCHLOROTHIAZIDE 199 195 12 17
DONEPEZIL HCL 185 185 13 13
TRAZODONE HCL 163 162 14 27
ATENOLOL 151 144 15 19
MIRTAZAPINE 150 142 16 16
METOPROLOL SUCCINATE 149 149 17 18
TRIAMTERENE-HCTZ 142 124 18 40
ZOLPIDEM TARTRATE 139 132 19 25
METFORMIN HCL 134 129 20 15
WARFARIN SODIUM 126 123 21 14
ALLOPURINOL 125 122 22 30
NAMENDA 121 121 23 10
LOSARTAN POTASSIUM 114 110 24 29
GLIPIZIDE ER 113 102 25 66
NEXIUM 109 109 26 22
MELOXICAM 104 95 27 24
ISOSORBIDE DINITRATE 101 101 28 91
SERTRALINE HCL 95 93 29 32
CLOPIDOGREL 91 86 30 33
TRAMADOL HCL 87 83 31 20
ATORVASTATIN CALCIUM 85 80 32 26
CLONIDINE HCL 85 72 32 36
FLUTICASONE PROPIONATE 85 79 32 52
ALENDRONATE SODIUM 82 82 35 23
GLIPIZIDE 76 71 36 40
TAMSULOSIN HCL 76 74 36 31
PLAVIX 75 71 38 34
PRAVASTATIN SODIUM 74 74 39 21
NIFEDIPINE ER 72 68 40 105
EXELON 70 67 41 53
KLOR-CON M20 65 65 42 50
FAMOTIDINE 63 59 43 65
CARBIDOPA-LEVODOPA 62 62 44 51
VERAPAMIL ER 61 54 45 58
CYMBALTA 61 61 45 37
PANTOPRAZOLE SODIUM 61 46 45 71
DIOVAN 58 58 48 79
SPIRONOLACTONE 53 49 49 76
SPIRIVA 52 52 50 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.